United States · FDA National Drug Code directory
MEPRON
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0173-0547_005bf875-7785-4b73-8c03-fa75737de8a9
- Product NDC
- 0173-0547
- Form
- SUSPENSION
- Composition / generic term
- atovaquone
- Labeler
- GlaxoSmithKline LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 19980918
- Source listing expiry
- 20271231
Source-listed ingredients
- ATOVAQUONE — 750 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 42 POUCH in 1 DOSE PACK (0173-0547-00) / 5 mL in 1 POUCH · 0173-0547-00
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →